The Combined Use of Metformin and Methotrexate in Psoriasis Patients with Metabolic Syndrome

Table 3

Treatment results of the study group (n = 35).

After (month)	PASI (before treatment) (X ± SD)	PASI (after treatment) (X ± SD)	% Reduction
1	21.8 ± 8.3	16.9 ± 7.7	22.48	0.01
2		14.3 ± 7.4	34.40	0.0002
3		9.0 ± 8.5	58.72	<0.001

Note. Mean PASI decreased each month. After three months of treatment, the mean PASI dropped by 58.72%. There was a statistically significant difference in PASI before and after treatment (, Student t-test).